This inventor holds 2 USPTO granted patents. Top assignee: Eisai Company, Limited. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2006
Title: Hiroyuki Ishizuka: Innovator in Antimicrobial Agents
Introduction
Hiroyuki Ishizuka is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial agents. With a total of 2 patents, Ishizuka's work has had a meaningful impact on medical science.
Latest Patents
Ishizuka's latest patents include innovative formulations that enhance the efficacy of antibiotics. One of his key inventions is the carbapenem hydrochloride trihydrate crystals, which are chemically stable and easily purified. This invention is particularly useful as an antimicrobial agent. The patent details a process for producing these crystals, which exhibit a powdery X-ray diffraction pattern with specific lattice distances. Another significant patent involves the preparation of basic antibiotic-inorganic acid addition salts and intermediate oxalates, further showcasing his expertise in pharmaceutical chemistry.
Career Highlights
Hiroyuki Ishizuka is currently associated with Eisai Company, Limited, a prominent player in the pharmaceutical industry. His work at Eisai has allowed him to focus on developing innovative solutions that address critical health challenges. His contributions have been instrumental in advancing the field of antimicrobial research.
Collaborations
Ishizuka has collaborated with esteemed colleagues such as Hiroyuki Chiba and Shin Sakurai. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hiroyuki Ishizuka's contributions to the field of pharmaceuticals, particularly in antimicrobial agents, highlight his role as a significant inventor. His patents reflect a commitment to advancing medical science and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
